Snowball logo
logo
CHRS_logo

Coherus BioSciences, Inc

CHRS β€’ NASDAQ
$1.45+$0.08Β  (5.84%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
326.6211257.226742.1750.94
COGS
57.5970.08159117.617.7418.57
Gross Profit
26914198.25149.424.4332.37
Operating Expenses & Income
Operating Income
(263.9)(256.9)(203.2)(111.7)(179.5)(156.6)
Total Operating Expenses
532.8397.8301.5261.1204189
R&D Expenses
363.1199.4109.493.3410598.47
Selling General & Admin Expenses
161188174.7139.5100.692.6
Earnings from Continuing Operations
Interest Expense
(22.96)(32.47)(40.54)(27.16)(9.001)(9.083)
Interest Income
------
Income Tax Expense
19.2234.87(0.38)28.51(332.8)(29.01)
Net Income
Net Income
(287.1)(291.8)(237.9)28.51(170.3)(131)
Supplemental
EBIT
(264.1)(259.3)(197.7)55.66(174.1)(152.1)
EBITDA
(260.7)(255.6)(193.9)60.94(170.2)(148.5)
In millions of USD, except % and values per 1 share